» Articles » PMID: 35854356

Stromal Vascular Fraction-enriched Fat Grafting As Treatment of Adherent Scars: Study Design of a Non-randomized Early Phase Trial

Overview
Journal Trials
Publisher Biomed Central
Date 2022 Jul 19
PMID 35854356
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In the last decades, autologous fat grafting has been used to treat adherent dermal scars. The observed regenerative and scar-reducing properties have been mainly ascribed to the tissue-derived stromal vascular fraction (tSVF) in adipose tissue. Adipose tissue's components augment local angiogenesis and mitosis in resident tissue cells. Moreover, it promotes collagen remodeling. We hypothesize that tSVF potentiates fat grafting-based treatment of adherent scars. Therefore, this study aims to investigate the effect of tSVF-enriched fat grafting on scar pliability over a 12-month period.

Methods And Design: A clinical multicenter non-randomized early phase trial will be conducted in two dedicated Dutch Burn Centers (Red Cross Hospital, Beverwijk, and Martini Hospital, Groningen). After informed consent, 46 patients (≥18 years) with adherent scars caused by burns, necrotic fasciitis, or degloving injury who have an indication for fat grafting will receive a sub-cicatricic tSVF-enriched fat graft. The primary outcome is the change in scar pliability measured by the Cutometer between pre- and 12 months post-grafting. Secondary outcomes are scar pliability (after 3 months), scar erythema, and melanin measured by the DSM II Colormeter; scar quality assessed by the patient and observer scales of the Patient and Observer Scar Assessment Scale (POSAS) 2.0; and histological analysis of scar biopsies (voluntary) and tSVF quality and composition. This study has been approved by the Dutch Central Committee for Clinical Research (CCMO), NL72094.000.20.

Conclusion: This study will test the clinical efficacy of tSVF-enriched fat grafting to treat dermal scars while the underlying working mechanism will be probed into too.

Trial Registration: Dutch Trial Register NL 8461. Registered on 16 March 2020.

Citing Articles

Autologous adipose-derived stromal vascular fraction (SVF) in scar treatment among patients with keloids and hypertrophic scars: a systematic review and meta-analysis of current practices and outcomes.

Mbiine R, Wayengera M, Kiwanuka N, Munabi I, Muwonge H, Nakanwagi C Am J Stem Cells. 2024; 12(5):98-111.

PMID: 38213639 PMC: 10776342.


The Effect of Tissue Stromal Vascular Fraction as Compared to Cellular Stromal Vascular Fraction to Treat Anal Sphincter Incontinence.

Chen W, He Z, Li S, Wu Z, Tan J, Yang W Bioengineering (Basel). 2023; 10(1).

PMID: 36671604 PMC: 9854502. DOI: 10.3390/bioengineering10010032.


[Progress on the mechanism and application of adipose-derived stem cells in promoting wound repair].

Sun T, Lu F, Gao J, Zhou C, Dong Z, Li B Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023; 38(12):1190-1195.

PMID: 36594151 PMC: 11821346. DOI: 10.3760/cma.j.cn501225-20220729-00320.

References
1.
Coleman S . Hand rejuvenation with structural fat grafting. Plast Reconstr Surg. 2002; 110(7):1731-44; discussion 1745-7. DOI: 10.1097/01.PRS.0000033936.43357.08. View

2.
Brown B, Moss T, McGrouther D, Bayat A . Skin scar preconceptions must be challenged: importance of self-perception in skin scarring. J Plast Reconstr Aesthet Surg. 2009; 63(6):1022-9. DOI: 10.1016/j.bjps.2009.03.019. View

3.
Balkin D, Samra S, Steinbacher D . Immediate fat grafting in primary cleft lip repair. J Plast Reconstr Aesthet Surg. 2014; 67(12):1644-50. DOI: 10.1016/j.bjps.2014.08.049. View

4.
Maione L, Memeo A, Pedretti L, Verdoni F, Lisa A, Bandi V . Autologous fat graft as treatment of post short stature surgical correction scars. Injury. 2014; 45 Suppl 6:S126-32. DOI: 10.1016/j.injury.2014.10.036. View

5.
Bruno A, Santi G, Fasciani L, Cempanari M, Palombo M, Palombo P . Burn scar lipofilling: immunohistochemical and clinical outcomes. J Craniofac Surg. 2013; 24(5):1806-14. DOI: 10.1097/SCS.0b013e3182a148b9. View